AXL and neoplasm: The contribution of AXL to CSCs was also confirmed in Lu99 cells and H1703-AXL cells: treatment with siAXL-1 and siAXL-2 significantly reduced the proportions of tumour spheres to 61.1% and 21.2%, respectively, in Lu99 cells (Supplementary Fig. S4).